Evidence mapPaperPMID 42369108Full record

ArticleFrontiers in medicine2026

Altered lipid profile in uterine leiomyoma: a focus on apolipoprotein A1 reduction and machine learning-based predictive modeling.

Feifei Zhang, Huizhen Lin, Huimin Yu, Yingsha Yao

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Feifei ZhangDepartment of Gynecology, Ningbo No. 2 Hospital, Wenzhou Medical University, Ningbo, China.
Huizhen LinDepartment of Gynecology, Ningbo No. 2 Hospital, Wenzhou Medical University, Ningbo, China.
Huimin YuDepartment of Gynecology, Ningbo No. 2 Hospital, Wenzhou Medical University, Ningbo, China.
Yingsha YaoDepartment of Gynecology, Ningbo No. 2 Hospital, Wenzhou Medical University, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to investigate the association between uterine leiomyomas (UL) and specific alterations in serum lipid profiles, and to evaluate the performance of machine learning models incorporating these markers for UL discrimination. Methods: In this age- and body mass index matched case-control study, 200 patients with histologically confirmed UL and 200 controls with normal uteri were enrolled. Fasting serum levels of total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, apolipoprotein A1 (ApoA1), and apolipoprotein B were measured. Logistic regression identified independent risk factors, which were then used to construct predictive models via several machine learning algorithms. Model performance was assessed using receiver operating characteristic curve analysis. Results: Patients with UL exhibited significantly lower serum levels of triglycerides and ApoA1 compared to controls. Multivariate analysis confirmed lower triglyceride and ApoA1 levels, along with higher gravidity and premenopausal status, as independent factors associated with UL. While individual lipid parameters showed limited discriminative power, integrative models combining these with clinical features achieved high performance. The Random Forest model demonstrated superior discriminative ability, with an area under the curve of 0.986. Conclusion: After rigorous confounding control, UL is independently associated with a distinct metabolic phenotype characterized by reduced serum triglyceride and ApoA1 levels. Prediction models integrating these lipid abnormalities with clinical data show promising potential for risk assessment, highlighting a unique interplay between lipid metabolism and UL pathogenesis worthy of further investigation.

Indexed as

apolipoprotein A1machine learningrisk assessmenttriglycerideuterine leiomyomas

Identifiers

PMID42369108
PMCPMC13303973

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.